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Abstract 22 
Background and aim: To understand whether any change in gastric emptying (GE) is 23 
physiologically relevant, it is important to identify its variability. Information regarding the 24 
variability of GE in overweight and obese individuals is lacking. The aim of this study was to 25 
determine the reproducibility of GE in overweight and obese males. 26 
Methods: Fifteen overweight and obese males [body mass index 30.3 (4.9) kg/m2] completed 27 
two identical GE tests 7 days apart.  GE of a standard pancake breakfast was assessed by 13C-28 
octanoic acid breath test. Data are presented as mean (+SD). 29 
Results: There were no significant differences in GE between test days (half time (t1/2): 179 30 
(15) and 176 (19 min), p = 0.56; lag time (tlag): 108 (14) and 104 (8) min, p = 0.26). Mean 31 
intra-individual coefficient of variation for t1/2 was 7.9% and tlag 7.5%.  Based on these 32 
findings, to detect a treatment effect in a paired design with a power of 80% and α = 0.05, 33 
minimum mean effect sizes for t1/2 would need to be ≥ 14.4 min and tlag ≥ 8.1 min. 34 
Conclusions: These data show that GE is reproducible in overweight and obese males and 35 
provide minimum mean effect sizes required to detect a hypothetical treatment effect in this 36 
population. 37 
  38 
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1. Introduction 39 
Measurement of gastric emptying (GE) is essential to understand changes in gastric 40 
symptoms and appetite in various pathologic conditions, and in response to treatments. For 41 
example, GE could play an important role in the aetiology of obesity through processes of 42 
satiety and satiation. However, to understand whether any change in GE is detectable and 43 
clinically meaningful, it is important to identify its day-to-day variability. The reproducibility 44 
of GE has been studied in various populations, including infants,1-2 children,3 critically ill 45 
patients,4 diabetics5 and healthy lean adult males6 and females.7 Surprisingly, despite being 46 
implicated in the pathogenesis of obesity8 and measured in response to numerous 47 
interventions9 information regarding the day-to-day variability of GE in overweight and obese 48 
individuals is lacking.  49 
 Previous studies have reported a mean intra-individual coefficient of variation for GE 50 
half time ranging from 6% in healthy infants1  to 73% in patients with functional dyspepsia.15 51 
This illustrates the large variation in the reproducibility of GE that can occur depending on 52 
the population studied and highlights the importance of establishing the intra-individual 53 
variability in the subject population of interest. Given some evidence that gut peptide10 and  54 
appetite responses may vary according to body composition or body mass index, it should not 55 
be assumed that outcomes observed in a group of lean individuals will be identical in 56 
overweight and obese individuals11. Individual differences in the person studied (e.g. 57 
neurological and hormonal differences12, anatomical differences such as the shape of the 58 
stomach13, diet, physical activity and psychological factors14) may all influence the 59 
reproducibility of GE. The intra-subject variability in GE might therefore be different in 60 
overweight and obese compared to lean individuals.  61 
The test conditions (e.g. the test meal used5) and the GE parameters reported16 may also 62 
influence the intra-individual variability. Knowledge of the reproducibility of different phases 63 
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of GE and hence GE parameters is important given the kinetic and temporal nature of GE and 64 
relation to appetite control.9 Although half time is generally the focus of GE studies as it is 65 
considered the most useful parameter in clinical practice, it does not reflect the complete 66 
pattern of GE. Since the 13C-octanoic acid breath test (13C-OBT) was proposed as a safe, 67 
reliable and non-radioactive alternative to scintigraphy for measurement of GE,17 the test has 68 
been widely used in a variety of populations including obese individuals.8 A number of GE 69 
parameters have been proposed that reflect the various phases of GE (e.g. Schommartz et 70 
al.18). However, little information exists on the reproducibility of the different parameters or 71 
phases of GE. 72 
Thus, using the 13C-OBT to measure GE, the aims of this study were to (i) determine 73 
the reproducibility of GE, (ii) compare the reproducibility of different GE parameters and (iii) 74 
calculate minimum effect sizes required to detect a hypothetical treatment effect in GE, in 75 
overweight and obese males. 76 
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2. Materials and Methods 77 
2.1 Participants and Design 78 
 Fifteen overweight and obese men [mean (±SD) body mass index  = 30.3 (4.9) kg/m2, age = 79 
34.9 (10.6) y, percent body fat = 32.1 (8.0) %] participated in the study. Height was measured 80 
without shoes to the nearest 0.5cm and weight to the nearest 0.01kg. Body composition was 81 
measured using air displacement plethysmography (Bodpod, Concord, CA).  All participants 82 
had no history of gastrointestinal disease or surgery, significant illness, or were taking any 83 
medication known to directly affect gastrointestinal motility or appetite. The medication 84 
participants reported taking included albuterol (n = 1), budesonide (n=1), fexofenadine (n = 1), 85 
atorvastatin/amlodipine and olmesartan (n = 1). Participants provided written informed 86 
consent prior to taking part in the study. The study received ethical approval from the 87 
Queensland University of Technology Research Ethics Committee. 88 
  Each participant participated in two identical GE test days 7 days apart. Participants 89 
were provided with a standardised evening meal to consume at home prior to both test days 90 
and were asked to then fast for 12 hours overnight until attending the laboratory the following 91 
morning. In addition, participants were instructed to refrain from strenuous exercise and 92 
alcohol for 24 hours beforehand and to avoid consumption of naturally 13C-enriched foods 93 
(e.g. corn or corn products, pineapple, kiwi fruit, cane sugar and exotic fruits) for at least two 94 
days prior to both test days. Test mornings commenced between 6am and 9am, and the time 95 
of day for repeat tests was standardised within participants. 96 
2.2 Gastric Emptying 97 
 GE parameters were calculated using the 13C-OBT.17 The egg yolk of a standardized pancake 98 
breakfast meal [1676 kJ (400 kcal); 15g (15%) PRO, 17g (37%) Fat, 48g (48%) CHO)] was 99 
labelled with 100mg 13C-octanoic acid (Cambridge Isotope Laboratories, Andover, USA). 100 
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Participants consumed the meal together with 250ml of water within 10 minutes. Breath 101 
samples were collected in 10ml glass Exetainer tubes (Labco, Buckinghamshire, UK) prior to 102 
the breakfast, immediately after, and subsequently at 15 minute intervals for 5 hours after 103 
breakfast. Participants remained in sedentary activities throughout. 104 
2.2.1 13C breath test analysis 105 
 13C enrichment of breath samples was measured by isotope ratio mass spectrometry (Hydra 106 
20-20) and compared to a reference gas (5% CO2, 75% N2, 20% O2 calibrated with a standard 107 
of 13CO2). Data were analysed according to Ghoos et al 17 and fitted to the original GE 108 
mathematical model  by non-linear regression analysis . The r2 coefficient between the 109 
modelled and raw data was calculated and accepted if r2>0.9. The conventional uncorrected 110 
time based parameters (tlag and t1/2) proposed by Ghoos et al.17  and the parameters latency 111 
time (tlat) and ascension time (tasc) proposed by Schommartz et al. (1998)18 were calculated. 112 
Latency time refers to the the initial delay in the cumulative 13C-excretion curve, thus 113 
reflecting the initial emptying phase and ascension time to the time course between the 114 
latency phase and the half excretion time, representing a period of high 13C-excretion rates18. 115 
2.3 Statistical Analysis 116 
 Paired t tests were used to compare differences between visits 1 and 2. The difference 117 
between results on the two separate days was plotted against the mean of the results for each 118 
subject, according to Bland and Altman.19 Intra-individual variability was expressed as the 119 
coefficient of intra-subject variation (CVintra; CVintra = SDd/(m√2) where SDd is the standard 120 
deviation of the differences between the repeated tests and m is the mean of the repeated tests 121 
4-5, 19). Based on day to day variability observed in these parameters, minimum effect sizes 122 
required to detect a hypothetical treatment effect with 80% power were calculated. Minimum 123 
differences that would be detected by a sample of fifteen subjects were also calculated. 124 
Statistical analysis was performed using PASW Statistics 18.0 (SPSS Inc., Chicago, IL) and 125 
7  
 
Graph Pad Prism version 6.0 (GraphPad Software, San Diego, CA, USA). Data are expressed 126 
as mean ± standard deviation (SD), unless otherwise stated. Statistical significance was set at 127 
P < 0.05. 128 
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3. Results 129 
Bland Altman plots for GE time based parameters are shown in Figure 1. For all GE 130 
parameters, no significant difference was found between the two test days (Table 1).  The 131 
mean difference between test days was small for all parameters. However the 95% limits of 132 
agreement were -35.9 to 42.1 min for t1/2 (Figure 1). As shown in Figure 1, one individual 133 
was outside the 95% limits of agreement with a mean difference between test days of 46 min 134 
for t1/2. This individual reported to adhere to the study protocol, therefore this change may 135 
represent the extreme of intra-individual variability. The mean CVintra varied depending on the 136 
parameter reported from a minimum of 7.5% (tlag) to a maximum of 11.4% (tasc) (Table 1).  137 
 138 
[FIGURE 1] 139 
 140 
 [TABLE 1] 141 
 142 
3.1 Relationships between Variables 143 
 Change in tlag from visit 1 to 2 was significantly correlated with change in t1/2 (r = 0.81, p < 144 
0.001, Figure 2). Changes in all parameters between visits 1 and 2 were significantly 145 
correlated (p <  0.05), except for tlat. Change in tlat was significantly correlated with change in 146 
tlag (r  = 0.77, p = 0.001). However, there was no significant correlation between change in tlat 147 
with change in t1/2 (r = 0.25, p = 0.36) or tasc (r = -0.011, p = 0.97, Figure 2).  148 
 149 
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[FIGURE 2] 150 
 151 
3.2 Calculation of minimum effect sizes for gastric emptying parameters 152 
 Based on the day-to-day variations observed, we calculated that in order to detect a treatment 153 
effect, in a paired design with a power of 80% and α = 0.05, minimum mean effect sizes for 154 
GE t1/2 would need to be ≥ 14.40min, tlag ≥ 8.1 min, tasc ≥ 13.9 min and tlat ≥ 3.8 min. An 155 
estimate of the minimum number of participants needed to detect significant differences in a 156 
paired design study assuming α = 0.05 and a power of 80% was calculated and used to 157 
construct a nomogram (Figure 3). To detect a 10% change the minimum number of 158 
participants needed for tlag and t1/2 would be 10, tlat 25 and tasc 14.  159 
 160 
[FIGURE 3] 161 
 162 
  163 
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4. Discussion 164 Knowledge of the day to day variability of gastric emptying is necessary to assist in both 165 designing studies and interpreting the clinical relevance of any changes if observed. This 166 
study provides evidence that GE is reproducible in overweight and obese males. In addition, 167 
these data show that the reproducibility and hence the sample size required to detect a 168 
significant difference in GE will vary depending on the parameter of interest.  169 
 Some evidence indicates that the release of gut peptides and appetite may be altered in 170 
obese individuals.10-11 For example, ghrelin is a significant determinant of GE in lean but not 171 
obese individuals.10 We therefore hypothesized that the day-to-day variability in GE might be 172 
different. However, our findings of a mean intra-individual coefficient of variation of ~ 8% 173 
for GE half time in healthy overweight and obese males, is comparable to studies in lean 174 
individuals using test meals similar in energy content.5, 20-21 In healthy lean adults, an intra-175 
individual coefficient of variation ranging from 7%21 to 30%22 has been reported for half time 176 
of solid meals, with the majority of studies indicating an intra-individual variability of 177 
between approximately 11-15%.16, 20-21, 23-25 Although others have reported a higher intra-178 
individual variability in GE of between 20-30% in healthy adults,17, 22, 26 differences in study 179 
methodologies may account for this inconsistency. The low energy content of the test meals 180 
used (ranging from 200 to 250 kcal) in the latter studies17, 22, 26 may contribute to the lower 181 
reproducibility.27 It is also possible that the true variability in GE may go undetected if the 182 
test meal does not challenge motility,28 therefore in the current study we used a test meal 183 
(400kcal) which reflects a more typical size of meal. Taken together, our findings indicate 184 
that unlike other populations where the variability of GE has been shown to be higher (e.g. 185 
diabetics,5 patients with functional dyspepsia,15 preterm infants2 and critically ill patients4), 186 
the reproducibility of GE in healthy overweight and obese males is similar to that reported in 187 
healthy lean adults. 188 
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 Our findings also indicate that the parameters used to characterise GE differ in their 189 
reproducibility. We found that the intra-individual variability was similarly lowest for tlag and 190 
t1/2 derived from the original 13C-OBT mathematical model17, than for other GE parameters. 191 
This finding is in contrast with others who have shown the lag phase or initial emptying to be 192 
less reproducible than subsequent emptying parameters16, 20. One explanation may be that GE 193 
was measured in these studies by scintigraphy and lag time derived by scintigraphy is known 194 
to be difficult to quantify.28 Chey et al.,28 examined the reproducibility of GE parameters 195 
measured by both 13C breath test and scintigraphy and reported that while for scintigraphy 196 
half time was considerably more reproducible, for the breath test lag time was more 197 
reproducible. Our findings suggest that in contrast to some scintigraphic studies, lag time 198 
derived by breath test is a reproducible GE parameter.  199 
 In addition to lag and half times, other parameters attempting to more accurately 200 
reflect the biphasic nature of GE have been proposed. By definition the same part of the 201 
13CO2 exhalation curve is used for the calculation of both tlag and t1/2 and both parameters have 202 
been shown to be highly correlated.18 As a result the different phases of GE (e.g. a delayed 203 
initial emptying but accelerated subsequent emptying or vice versa) could be difficult to 204 
distinguish. This prompted Schommartz et al.,18 to propose the parameters latency time and 205 
ascension time. Although, little information exists on the reproducibility of these parameters, 206 
we found intra-individual coefficient of variations of ~ 11% and 9% for latency and ascension 207 
times respectively indicating that both parameters are reproducible in overweight and obese 208 
males. Interestingly, we also found that while changes in lag time and half time from visits 1 209 
to 2 were highly correlated, changes in latency and ascension times were not. These findings 210 
suggest that these additional parameters may be more sensitive to detecting changes in 211 
different phases of GE, and would be useful to determine in addition to the conventional 212 
parameters in repeated measures studies. 213 
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 Information regarding the day-to-day variability of GE is necessary to determine 214 
appropriate sample sizes when designing studies. For example, Lartigue et al.,5 calculated that 215 
to detect a 20% change in GE half time in a paired design study, 7 healthy subjects would be 216 
required whereas 18 diabetics would be required. We found that in overweight and obese 217 
males a 20% change in all parameters (lag, half, latency and ascension times) could be 218 
detected with a sample size of 7 participants. These results demonstrate that only a small 219 
number of participants are needed to detect clinically relevant changes in GE. As GE studies 220 
are often carried out in small numbers e.g. measured pre and post surgical procedure, these 221 
findings illustrate the potential efficiency of undertaking smaller studies before larger studies 222 
are undertaken. 223 
 There are various methodological aspects to this study and GE reproducibility studies 224 
in general which deserve further consideration. How best to represent intra-individual 225 
variability remains a matter of debate.29 We have discussed primarily the intra-individual 226 
coefficient of variation as it allows comparison across the majority of other studies and hence 227 
populations and methods. The parameters used to describe GE measured by 13C-OBT also 228 
vary. Some report half and lag times that are corrected to scintigraphy equivalent values.17, 22, 229 
25 However, the rationale for the correction of values has been questioned as it is possible to 230 
obtain negative and physiologically insignificant values.18 For this reason, we report the 231 
original uncorrected lag and half times proposed by Ghoos et al.,17, similar to others.1-2, 4, 23-24, 232 
28 It should also be noted that many other parameters in addition to those described in the 233 
current study have been proposed for the 13C-OBT. We analysed the reproducibility of four 234 
commonly used parameters which aim to characterise the biphasic nature of GE. In addition, 235 
the reproducibility of a test meal consisting of a less balanced composition or different energy 236 
content may be different. Similarly, our findings apply to healthy overweight and obese males 237 
and therefore future studies in conditions such as gastroparesis and in females are warranted. 238 
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Lastly, the 13C-OBT does not provide direct imaging of gastric function, and therefore studies 239 
measuring GE using other techniques would be useful to confirm the present findings in 240 
overweight and obese individuals. 241 
 In the current study we did not determine the accuracy of the 13C-OBT against the 242 
‘gold standard’ scintigraphy. However, scintigraphic measurements may be hampered in 243 
obese individuals as defining the gastric areas of interest can be difficult and consequently the 244 
acceptance of scintigraphy as the ‘gold standard’ has been considered by some an arbitrary 245 
choice.25 The optimal method of measuring GE in overweight and obese individuals remains 246 
unclear. It is difficult to examine the accuracy of scintigraphy in obese individuals, as it is the 247 
‘gold standard’. Other non-invasive non-radioactive methods such as the paracetamol 248 
absorption test and ultrasound have only been validated for liquid emptying and ultrasound in 249 
particular is considered a suboptimal method for measuring GE in overweight or obese 250 
individuals. In contrast, the 13C-OBT measures solid meal emptying, has been validated 251 
against scintigraphy, has a day to day variability comparable to scintigraphy,17 is sensitive 252 
enough to detect pharmacological influences on GE30 and has been successfully used in obese 253 
individuals.8 Our findings further suggest that GE measured by 13C-OBT is reproducible in 254 
overweight and obese individuals and therefore the 13C-OBT represents a promising method 255 
for measuring changes in GE in this population. 256 
 In summary, although studies have measured the reproducibility of GE using different 257 
methods and in different populations, to the best of our knowledge, this is the first study to 258 
investigate the reproducibility of GE in an overweight and obese population specifically. Our 259 
findings demonstrate that (i) the reproducibility of GE is similar to that found in lean adults, 260 
(ii) the reproducibility varies depending on the GE parameter reported, and (iii) that relatively 261 
small sample sizes are sufficient to detect clinically significant changes in GE in overweight 262 
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and obese males. This knowledge is important given the increasing number of GE studies 263 
being undertaken in this population. 264 
 265 
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Legend for Figures 375 
 376 
Figure 1. Bland–Altman plots showing the difference between visits 1 and 377 
2 (y axis) plotted against the mean for the two visits (x axis) for a) t lag, lag 378 
time, b) t1/2, half time, c) t lat, latency time and d) tasc, ascension time. 379 
Solid line indicates mean bias. Dashed lines indicate 95% limits of 380 
agreement. n = 15. 381 
 382 
Figure 2. Scatter plots of the relation between the change - from visit 1 to visit 2 - in 383 
(a) lag time (tlag) and half time (t1/2) (r = 0.81, p < 0.001), and b) latency time (tlat) and 384 
ascension time (tasc) (r = -0.01, p = 0.97). n = 15. 385 
 386 
Figure 3. Minimum number of participants needed to detect significant differences in 387 
a paired design in a) latency time (tlat), b) ascension time (tasc), c) half time (t1/2),and 388 
d) lag time (tlag), assuming a power of 80% and α = 0.05.  389 
 
 
 
 
 
 
 
 
 
 
 
